Fig. 6.
The predicted structures of 32 selected human milk glycans. The 32 selected HMGs include (A) seven glycan targets identified as VP8*N155 binders, (B) four glycan targets identified as VP8*N155 binders after treated by α1,2-fucosidase, (C) nine glycan targets identified as VP8*RV3 binders, and (D) 10 glycan targets identified as VP8*B223 binders. The structures shown are based on the predominant structure(s) in each glycan target determined using the metadata (lectin and antibody binding and tandem MS analysis) available on each.